Crossref Citations
This article has been cited by the following publications. This list is generated based on data provided by
Crossref.
Emmanuelli, Julien
and
Desenclos, Jean‐Claude
2005.
Harm reduction interventions, behaviours and associated health outcomes in France, 1996–2003.
Addiction,
Vol. 100,
Issue. 11,
p.
1690.
Amarapurkar, Anjali D.
and
Sangle, N.A.
2005.
Histological spectrum of liver in HIV – Autopsy study.
Annals of Hepatology,
Vol. 4,
Issue. 1,
p.
47.
Bonnet, Nicolas
2006.
Intérêt d’un programme d’échange de seringues en pharmacie d’officine pour les usagers de drogues par voie intraveineuse.
La Presse Médicale,
Vol. 35,
Issue. 12,
p.
1811.
Lindenburg, Catharina EA
Krol, Anneke
Smit, Colette
Buster, Marcel CA
Coutinho, Roel A
and
Prins, Maria
2006.
Decline in HIV incidence and injecting, but not in sexual risk behaviour, seen in drug users in Amsterdam: a 19-year prospective cohort study.
AIDS,
Vol. 20,
Issue. 13,
p.
1771.
Massari, Véronique
Viboud, Cécile
Dorléans, Yves
and
Flahault, Antoine
2006.
Decline in HCV testing and compliance with guidelines in patients of Sentinelles general practitioners, 1996–2002.
European Journal of Epidemiology,
Vol. 21,
Issue. 5,
p.
397.
Aubisson, S.
Carrieri, P.
Lovell, A.-M.
Ben Diane, M.-K.
Peretti-Watel, P.
and
Spire, B.
2006.
Quels nouveaux outils pour prévenir et évaluer les pratiques à risque chez les injecteurs de drogue face au VHC ? Réflexions sur les salles d’injection et les outils de mesure des prises de risques.
Revue d'Épidémiologie et de Santé Publique,
Vol. 54,
Issue. ,
p.
69.
Muga, Roberto
Sanvisens, Arantza
Bolao, Ferran
Tor, Jordi
Santesmases, Javier
Pujol, Ramon
Tural, Cristina
Langohr, Klaus
Rey-Joly, Celestino
and
Muñoz, Alvaro
2006.
Significant reductions of HIV prevalence but not of hepatitis C virus infections in injection drug users from metropolitan Barcelona: 1987–2001.
Drug and Alcohol Dependence,
Vol. 82,
Issue. ,
p.
S29.
Carrieri, M. P.
Amass, L.
Lucas, G. M.
Vlahov, D.
Wodak, A.
and
Woody, G. E.
2006.
Buprenorphine Use: The International Experience.
Clinical Infectious Diseases,
Vol. 43,
Issue. Supplement 4,
p.
S197.
Lert, F.
2006.
Peut-on enrayer la transmission de l’hépatite C liée à l’usage de drogue ?.
Revue d'Épidémiologie et de Santé Publique,
Vol. 54,
Issue. ,
p.
61.
Mathei, C.
Shkedy, Z.
Denis, B.
Kabali, C.
Aerts, M.
Molenberghs, G.
Van Damme, P.
and
Buntinx, F.
2006.
Evidence for a substantial role of sharing of injecting paraphernalia other than syringes/needles to the spread of hepatitis C among injecting drug users.
Journal of Viral Hepatitis,
Vol. 13,
Issue. 8,
p.
560.
Delarocque-Astagneau, E.
Pillonel, J.
de Valk, H.
Perra, A.
Laperche, S.
and
Desenclos, J.-C.
2006.
Les modes de transmission du virus de l’hépatite C : approches méthodologiques.
Revue d'Épidémiologie et de Santé Publique,
Vol. 54,
Issue. ,
p.
5.
Mateu-Gelabert, Pedro
Treloar, Carla
Calatayud, Víctor Agulló
Sandoval, Milagros
Zurián, Juan Carlos Valderrama
Maher, Lisa
Rhodes, Tim
and
Friedman, Samuel R.
2007.
How can hepatitis C be prevented in the long term?.
International Journal of Drug Policy,
Vol. 18,
Issue. 5,
p.
338.
Hagan, Holly
Des Jarlais, Don C.
Stern, Rebecca
Lelutiu-Weinberger, Corina
Scheinmann, Roberta
Strauss, Shiela
and
Flom, Peter L.
2007.
HCV Synthesis Project: Preliminary analyses of HCV prevalence in relation to age and duration of injection.
International Journal of Drug Policy,
Vol. 18,
Issue. 5,
p.
341.
Vickerman, P
Hickman, M
and
Judd, A
2007.
Modelling the impact on Hepatitis C transmission of reducing syringe sharing: London case study.
International Journal of Epidemiology,
Vol. 36,
Issue. 2,
p.
396.
Lucidarme, Damien
Decoster, Anne
Fremaux, Didier
Harbonnier, Jean
Jacob, Claude
Vosgien, Véronique
Josse, Pascal
Villeger, Pierre
Henrio, Cécile
Prouvost-Keller, Bernard
Saccardy, Claire
Lemaire, Muriel
Vazeille, Gérard
Duchene, Claude
Thuillier, Michel
Colbeaux, Christian
Lefebvre, Anne-Marie
Forzy, Gérard
and
Filoche, Bernard
2007.
Routine practice HCV infection screening with saliva samples: multicentric study in an intravenous drug user population.
Gastroentérologie Clinique et Biologique,
Vol. 31,
Issue. 5,
p.
480.
Delarocque-Astagneau, Elisabeth
Pillonel, Josiane
De Valk, Henriette
Perra, Alberto
Laperche, Syria
and
Desenclos, Jean-Claude
2007.
An Incident Case–Control Study of Modes of Hepatitis C Virus Transmission in France.
Annals of Epidemiology,
Vol. 17,
Issue. 10,
p.
755.
Rhodes, Tim
Žikic´, Bojan
Prodanovic´, Ana
Kuneski, Elena
and
Bernays, Sarah
2008.
Hygiene and uncertainty in qualitative accounts of hepatitis C transmission among drug injectors in Serbia.
Social Science & Medicine,
Vol. 66,
Issue. 6,
p.
1437.
Chossegros, P.
Mélin, P.
Hézode, C.
Bourlière, M.
Pol, S.
Fhima, A.
Filoche, B.
Trépo, C.
Couzigou, P.
Ouzan, D.
and
Gagnon, A.
2008.
A French prospective observational study of the treatment of chronic hepatitis C in drug abusers.
Gastroentérologie Clinique et Biologique,
Vol. 32,
Issue. 10,
p.
850.
Esteban, Juan I.
Sauleda, Silvia
and
Quer, Josep
2008.
The changing epidemiology of hepatitis C virus infection in Europe.
Journal of Hepatology,
Vol. 48,
Issue. 1,
p.
148.
De, P.
Roy, É.
Boivin, J.‐F.
Cox, J.
and
Morissette, C.
2008.
Risk of hepatitis C virus transmission through drug preparation equipment: a systematic and methodological review.
Journal of Viral Hepatitis,
Vol. 15,
Issue. 4,
p.
279.